Video

Anat Loewenstein Talks ForeSeeHome, Unmet Needs in Retinal Disease

Author(s):

The biggest unmet need nowadays in retina disease is geographic atrophy..."

In the second installment of MD Magazine’s sitdown with Tel Aviv Medical Center Ophthalmology Department Chair Anat Loewenstein, she spoke of needs to be addressed in the treatment of patients with retina diseases as well as other projects she is involved in.

“I think the biggest unmet need nowadays in retina disease is geographic atrophy and the need for frequent treatment and monitoring,” she said.

“I’m involved in many research projects, and I think the most exciting ones have to do with monitoring of the disease and with automated detection of choroidal neovascular activity,” Loewenstein said, before discussing ForeSeeHome, the home-based age-related macular degeneration monitoring device that she expects to be adopted worldwide in the coming years.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
© 2025 MJH Life Sciences

All rights reserved.